Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2018 | 1 |
2019 | 1 |
2020 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Cancer-immune interactions in ER-positive breast cancers: PI3K pathway alterations and tumor-infiltrating lymphocytes.
Breast Cancer Res. 2019 Aug 7;21(1):90. doi: 10.1186/s13058-019-1176-2.
Breast Cancer Res. 2019.
PMID: 31391067
Free PMC article.
PI3K pathway protein analyses in metastatic breast cancer patients receiving standard everolimus and exemestane.
Kruger DT, Opdam M, van der Noort V, Sanders J, Nieuwenhuis M, de Valk B, Beelen KJ, Linn SC, Boven E.
Kruger DT, et al. Among authors: beelen kj.
J Cancer Res Clin Oncol. 2020 Nov;146(11):3013-3023. doi: 10.1007/s00432-020-03291-x. Epub 2020 Jun 21.
J Cancer Res Clin Oncol. 2020.
PMID: 32566979
Free PMC article.
Clinical Trial.
Item in Clipboard
Hierarchical clustering of activated proteins in the PI3K and MAPK pathways in ER-positive, HER2-negative breast cancer with potential therapeutic consequences.
Kruger DT, Beelen KJ, Opdam M, Sanders J, van der Noort V, Boven E, Linn SC.
Kruger DT, et al. Among authors: beelen kj.
Br J Cancer. 2018 Oct;119(7):832-839. doi: 10.1038/s41416-018-0221-8. Epub 2018 Oct 5.
Br J Cancer. 2018.
PMID: 30287915
Free PMC article.
Item in Clipboard
Cite
Cite